You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 152 No. 9, September 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Article
 This Article
 •Full text
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (30)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neonatology and Infant Care
 •Alert me on articles by topic

Variation Among Neonatal Intensive Care Units in Narcotic Administration

Doron J. Kahn; Douglas K. Richardson, MD, MBA; James E. Gray, MD, MS; Francis Bednarek, MD; Lewis P. Rubin, MD; Bhavesh Shah, MD; Ivan D. Frantz III, MD; DeWayne M. Pursley, MD

Arch Pediatr Adolesc Med. 1998;152:844-851.

Objectives  To compare rates of narcotic administration for medically treated neonates in different neonatal intensive care units (NICUs) and to compare treated and untreated neonates to assess whether narcotics provided advantages or disadvantages for short-term outcomes, such as cardiovascular stability (ie, blood pressure and heart rate), hyperbilirubinemia, duration of respiratory support, growth, and the incidence of intraventricular hemorrhage.

Study Design  The medical charts of neonates weighing less than 1500 g, admitted to 6 NICUs (A-F), were abstracted. Neonates who had a chest tube or who had undergone surgery were excluded from the study, leaving the records of 1171 neonates. We modeled outcomes by linear or logistic regression, controlling for birth weight (<750, 750-999, and 1000-1499 g) and illness severity (low, 0-9; medium, 10-19; high, >=20) using the Score for Neonatal Acute Physiology (SNAP), and adjusted for NICU.

Results  Narcotic use varied by birth weight (<750 g, 21%; 750-999 g, 13%; and 1000-1499 g, 8%), illness severity (low, 9%; medium, 19%; and high, 37%), day (1, 11%; 3, 6%; and 14, 2%), and NICU. We restricted analyses to the 1018 neonates who received mechanical ventilation on day 1. Logistic regression, adjusting for birth weight and SNAP, confirmed a 28.6-fold variation in narcotic administration (odds ratios, 4.1-28.6 vs NICU A). Several short-term outcomes also were associated with narcotic use, including more than 33 g of fluid retention on day 3 and a higher direct bilirubin level (6.8 µmol/L higher [0.4 mg/dL higher], P=.03). There were no differences in weight gain at 14 and 28 days or mechanical ventilatory support on days 14 and 28. Narcotic use was not associated with differences in worst blood pressure or heart rate or with increased length of hospital stay.

Conclusions  Our study found a 28.6-fold variation among NICUs in narcotic administration in very low-birth-weight neonates. We were unable to detect any major advantages or disadvantages of narcotic use. We did not assess iatrogenic abstinence syndrome or long-term outcomes. These results indicate the need for randomized trials to rationalize these widely differing practices.


From the Joint Program in Neonatology, Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Children's Hospital, and Harvard Medical School, Boston, Mass (Mr Kahn and Drs Richardson, Gray, and Pursley); the Department of Maternal and Child Health, Harvard School of Public Health, Boston (Dr Richardson); Memorial Health Care and University of Massachusetts, Worcester (Dr Bednarek); the Department of Pediatrics, Brown University and Women and Infant's Hospital, Providence, RI (Dr Rubin); the Division of Neonatology, Baystate Medical Center, Springfield, Mass (Dr Shah); and the Division of Newborn Medicine, Floating Hospital for Children at Tufts New England Medical Center, Boston (Dr Frantz). Mr Kahn is a medical student at Albert Einstein College of Medicine, New York, NY.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Implementation and Case-Study Results of Potentially Better Practices to Improve Pain Management of Neonates
Dunbar et al.
Pediatrics 2006;118:S87-S94.
ABSTRACT | FULL TEXT  

Assessing Postoperative Pain in Neonates: A Multicenter Observational Study
Taylor et al.
Pediatrics 2006;118:e992-e1000.
ABSTRACT | FULL TEXT  

Morphine in ventilated neonates: its effects on arterial blood pressure
Simons et al.
Arch. Dis. Child. Fetal Neonatal Ed. 2006;91:F46-F51.
ABSTRACT | FULL TEXT  

Morphine Administration and Short-term Pulmonary Outcomes Among Ventilated Preterm Infants
Bhandari et al.
Pediatrics 2005;116:352-359.
ABSTRACT | FULL TEXT  

Morphine Sedation in Ventilated Newborns: Who Are We Treating?
Levene
Pediatrics 2005;116:492-493.
FULL TEXT  

Neonatal disease severity scoring systems
Dorling et al.
Arch. Dis. Child. Fetal Neonatal Ed. 2005;90:F11-F16.
ABSTRACT | FULL TEXT  

Routine Morphine Infusion in Preterm Newborns Who Received Ventilatory Support: A Randomized Controlled Trial
Simons et al.
JAMA 2003;290:2419-2427.
ABSTRACT | FULL TEXT  

Do We Still Hurt Newborn Babies?: A Prospective Study of Procedural Pain and Analgesia in Neonates
Simons et al.
Arch Pediatr Adolesc Med 2003;157:1058-1064.
ABSTRACT | FULL TEXT  

Nursing management of children's pain: Current evidence and future directions for research
Franck
Journal of Research in Nursing 2003;8:330-353.
ABSTRACT  

Inter-Neonatal Intensive Care Unit Variation in Discharge Timing: Influence of Apnea and Feeding Management
Eichenwald et al.
Pediatrics 2001;108:928-933.
ABSTRACT | FULL TEXT  

Persistent Pulmonary Hypertension of the Newborn in the Era Before Nitric Oxide: Practice Variation and Outcomes
Walsh-Sukys et al.
Pediatrics 2000;105:14-20.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.